Biogen, Inc. (BIIB)
217.15
+1.72
(+0.80%)
USD |
NASDAQ |
Sep 11, 16:00
217.15
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Return Level : 217.15 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 217.15 |
| September 10, 2026 | 215.43 |
| September 09, 2026 | 210.73 |
| September 08, 2026 | 212.50 |
| September 04, 2026 | 220.83 |
| September 03, 2026 | 224.51 |
| September 02, 2026 | 222.67 |
| September 01, 2026 | 216.04 |
| August 31, 2026 | 216.65 |
| August 28, 2026 | 218.50 |
| August 27, 2026 | 221.50 |
| August 26, 2026 | 221.07 |
| August 25, 2026 | 220.77 |
| August 24, 2026 | 218.12 |
| August 21, 2026 | 216.78 |
| August 20, 2026 | 214.35 |
| August 19, 2026 | 221.56 |
| August 18, 2026 | 212.55 |
| August 17, 2026 | 209.15 |
| August 14, 2026 | 209.83 |
| August 13, 2026 | 210.65 |
| August 12, 2026 | 208.87 |
| August 11, 2026 | 203.89 |
| August 10, 2026 | 207.13 |
| August 07, 2026 | 207.94 |
| Date | Value |
|---|---|
| August 06, 2026 | 206.28 |
| August 05, 2026 | 206.63 |
| August 04, 2026 | 208.45 |
| August 03, 2026 | 201.82 |
| July 31, 2026 | 202.95 |
| July 30, 2026 | 207.93 |
| July 29, 2026 | 209.23 |
| July 28, 2026 | 205.61 |
| July 27, 2026 | 200.14 |
| July 24, 2026 | 202.19 |
| July 23, 2026 | 200.62 |
| July 22, 2026 | 197.74 |
| July 21, 2026 | 203.16 |
| July 20, 2026 | 199.95 |
| July 17, 2026 | 205.99 |
| July 16, 2026 | 208.92 |
| July 15, 2026 | 197.24 |
| July 14, 2026 | 191.95 |
| July 13, 2026 | 209.03 |
| July 10, 2026 | 199.15 |
| July 09, 2026 | 198.91 |
| July 08, 2026 | 200.36 |
| July 07, 2026 | 205.70 |
| July 06, 2026 | 208.46 |
| July 02, 2026 | 216.12 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ionis Pharmaceuticals, Inc. | 54.21 |
| AbbVie, Inc. | 442.89 |
| Regeneron Pharmaceuticals, Inc. | 788.74 |
| Gilead Sciences, Inc. | 209.46 |
| Vertex Pharmaceuticals, Inc. | 515.44 |